Chemotherapy can and frequently does cause hiccups, with studies reporting that roughly 15 to 28 percent of patients receiving certain drug regimens experience them during or shortly after treatment. That range is far higher than most people expect, and the hiccups that develop can be far more disruptive than the ordinary kind. While an everyday bout of hiccups resolves in minutes, chemo-related hiccups sometimes persist for hours or days, interfering with eating, sleeping, and the energy reserves that patients need most. The good news is that the causes are increasingly well understood, and several effective remedies exist.
How Common Are Chemo-Related Hiccups
The numbers vary depending on which drugs a patient receives and how the question is asked, but the rates are consistently higher than most oncology teams historically acknowledged. A cross-sectional study of 160 chemotherapy patients found hiccups in about 23 percent of them.1PubMed. Hiccups in Cancer Patients Receiving Chemotherapy: A Cross-Sectional Study A larger survey that contacted patients by phone after platinum-based chemotherapy reported a rate of 28 percent.2PLOS ONE. What percentage of patients with cancer develop hiccups with oxaliplatin- or cisplatin-based chemotherapy? A compilation of patient-reported outcomes An online survey of cancer patients found that 16 percent reported experiencing hiccups with their cancer therapy, with over a quarter of those saying the hiccups occurred frequently around treatment time.3PubMed. Frequency and Symptomatology of Hiccups in Patients With Cancer: Using an On-Line Medical Community to Better Understand the Patient Experience A randomized trial enrolling 654 patients found acute hiccups developing in roughly 15 to 17 percent of participants after chemotherapy.4PubMed Central. Patient-directed behavioral-physical interventions to alleviate acute hiccups associated with chemotherapy: a prospective randomized controlled trial
Those numbers probably undercount the real frequency. Until recently, hiccups were not captured in standard adverse-event reporting forms for clinical trials, so they tended to go unrecorded unless a patient brought them up or they became severe. Patients themselves sometimes dismiss hiccups as too minor to mention when they are already dealing with nausea, fatigue, and pain. The gap between what patients actually experience and what gets documented has made chemo-related hiccups one of the more underappreciated side effects.
It Is Often the Steroids, Not the Chemo Drug Itself
One of the most important things to understand about chemo-related hiccups is that the chemotherapy drug may not be the primary culprit. Patients receiving cisplatin or oxaliplatin typically also receive high-dose dexamethasone, a corticosteroid given as part of the antiemetic regimen to prevent nausea and vomiting. A number of case reports and studies have linked dexamethasone specifically to hiccups, and some researchers have argued that in many cases where hiccups are blamed on the chemotherapy agent, the steroid is the more likely cause.5PubMed. Severe hiccups during chemotherapy: corticosteroids the likely culprit One study of patients receiving cisplatin-based treatment with dexamethasone and a class of anti-nausea drugs called NK1 receptor antagonists found that nearly 45 percent experienced hiccups of any grade, with about a third experiencing hiccups that were moderate or worse.6SpringerLink / International Journal of Clinical Oncology. Evaluation of factors associated with clinically problematic hiccups in cisplatin-containing treatment with dexamethasone and neurokinin 1 receptor antagonists
This distinction matters practically. If the steroid is driving the hiccups rather than the platinum drug, you don’t necessarily need to change your chemotherapy. You may just need to adjust the anti-nausea medications, which is a much simpler fix. Your oncology team can investigate this by looking at the timing: dexamethasone-related hiccups typically begin within a day or two of the steroid dose and resolve as the steroid clears.
Why Hiccups Happen During Treatment
A hiccup is a sudden, involuntary contraction of the diaphragm followed by a snap closure of the vocal cords, which produces that characteristic “hic” sound. This process is governed by a reflex arc with three parts: sensory nerves (the phrenic, vagus, and sympathetic nerves) that detect stimulation, a processing center in the brainstem, and motor nerves that signal the diaphragm and the muscles between your ribs to contract.7Journal of Neurogastroenterology and Motility. Hiccup: Mystery, Nature and Treatment Anything that irritates or stimulates any part of this arc can trigger hiccups.
Chemotherapy and its supportive medications can activate this reflex in several ways. Dexamethasone appears to influence brainstem signaling, possibly through its effects on chemical messengers in the brain. Corticosteroid receptors are distributed throughout the brainstem and hypothalamus, and the way these receptors respond to dexamethasone may lower the threshold for the hiccup reflex to fire.8PubMed Central. Identification of Factors Associated With Clinically Problematic Hiccups in Male Patients Receiving Cisplatin-based Treatment With Dexamethasone and Aprepitant: A Subgroup Analysis Meanwhile, the brain chemicals dopamine, serotonin, and gamma-aminobutyric acid (GABA) all play roles in modulating the hiccup reflex, and several chemo-adjacent drugs affect the balance of these signals.9PubMed Central. Neurotransmitters in hiccups Cisplatin itself can also irritate the vagus nerve through direct effects on the stomach and esophagus, adding another trigger.
Who Is Most at Risk
The single most consistent risk factor across studies is being male. Men develop chemo-related hiccups far more often than women. One analysis found that male sex carried roughly double the odds of developing hiccups with platinum-based chemotherapy.2PLOS ONE. What percentage of patients with cancer develop hiccups with oxaliplatin- or cisplatin-based chemotherapy? A compilation of patient-reported outcomes Another study pegged the odds ratio for men even higher, identifying male sex alongside higher cisplatin doses and high-dose dexamethasone as independent risk factors.10Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). Study on Risk Factors for Hiccups Induced by Cisplatin-based Chemotherapy
Why men are more vulnerable is not fully understood. Researchers have proposed that hormonal differences, particularly the effects of androgens on muscle tissue, could play a role. There is also evidence that the distribution and sensitivity of corticosteroid receptors in the brain differ between sexes. Animal studies suggest the hypothalamus, which is involved in generating hiccups, shows greater corticosteroid sensitivity in males.8PubMed Central. Identification of Factors Associated With Clinically Problematic Hiccups in Male Patients Receiving Cisplatin-based Treatment With Dexamethasone and Aprepitant: A Subgroup Analysis
Beyond sex, higher doses of cisplatin and higher doses of dexamethasone both increase the risk. Interestingly, aprepitant and fosaprepitant, which are NK1 receptor antagonists given to prevent nausea, have also been associated with higher hiccup rates. One study found that patients receiving these drugs had about twice the odds of developing hiccups compared to those who did not receive them.2PLOS ONE. What percentage of patients with cancer develop hiccups with oxaliplatin- or cisplatin-based chemotherapy? A compilation of patient-reported outcomes This creates an uncomfortable paradox: some of the drugs used to make chemotherapy more tolerable may be contributing to a different problem.
When Hiccups Need Medical Attention
A brief episode of hiccups during or after a chemo infusion, lasting minutes to a few hours, is annoying but usually resolves on its own. The concern grows when hiccups persist beyond 48 hours or recur with every treatment cycle. Persistent hiccups can disrupt sleep, make eating difficult, and contribute to exhaustion and weight loss in patients who are already physically depleted. In the online survey mentioned earlier, 30 percent of cancer patients with hiccups said they interfered with leisure activities, and over 15 percent said they interfered with their ability to enjoy meals.3PubMed. Frequency and Symptomatology of Hiccups in Patients With Cancer: Using an On-Line Medical Community to Better Understand the Patient Experience
Hiccups lasting more than 24 hours also warrant investigation for an underlying cause beyond the drugs themselves. In cancer patients, persistent hiccups can sometimes signal something like an electrolyte imbalance. One case report documented persistent hiccups in a cancer patient that turned out to be caused by low sodium levels from a condition called syndrome of inappropriate antidiuretic hormone secretion.11PubMed Central. Persistent hiccups in cancer patient: a presentation of syndrome of inappropriate antidiuretic hormone induced hyponatremia Tumors that press on the diaphragm or the phrenic nerve can also cause hiccups independent of chemotherapy.12Journal of Hospice and Palliative Care. Treatment of Lung Cancer-Related Intractable Hiccups Using Pulsed Radiofrequency: Clinical Experience The point is not to alarm you but to encourage reporting hiccups to your care team rather than writing them off, especially if they won’t quit.
Switching Steroids as a First-Line Fix
Because dexamethasone is such a common trigger, one of the most effective and well-studied interventions is simply replacing it with a different corticosteroid. Methylprednisolone provides equivalent anti-nausea protection but seems far less likely to provoke hiccups. A randomized phase III crossover trial tested this directly: patients whose dexamethasone was rotated to methylprednisolone saw their hiccup intensity drop dramatically, from a mean severity score of 3.5 down to 0.9, with no increase in nausea or vomiting. When patients on the methylprednisolone arm were crossed over to dexamethasone, hiccup severity went back up.13PubMed Central. Antiemetic Corticosteroid Rotation from Dexamethasone to Methylprednisolone to Prevent Dexamethasone-Induced Hiccup in Cancer Patients Treated with Chemotherapy: A Randomized, Single-Blind, Crossover Phase III Trial
An earlier study using the same approach found that 85 percent of patients had complete resolution of hiccups after switching to methylprednisolone, while nausea control was maintained.14PubMed Central. Treatment of dexamethasone-induced hiccup in chemotherapy patients by methylprednisolone rotation Prednisolone has also been used as a substitute with similar success.15PubMed. Corticosteroid rotation to alleviate dexamethasone-induced hiccup: a case series at a single institution If you develop hiccups during chemotherapy, asking your oncologist about switching your antiemetic steroid is one of the simplest and best-supported options. It doesn’t require adding new drugs or changing your cancer treatment itself.
Medications That Can Stop Persistent Hiccups
When steroid rotation isn’t enough, or when the hiccups are not driven by dexamethasone, a number of medications have been used to treat persistent and intractable hiccups. A systematic review identified ten drugs with evidence of success: baclofen, gabapentin, haloperidol, metoclopramide, midazolam, nifedipine, nimodipine, orphenadrine, amitriptyline, and valproic acid.16PubMed. Pharmacologic Interventions for Intractable and Persistent Hiccups: A Systematic Review No single one of these is universally effective, and the evidence base is largely composed of case reports and small series rather than large trials. In practice, oncologists tend to try baclofen, gabapentin, or metoclopramide first and escalate from there.
Gabapentin has attracted particular attention in palliative care settings. Multiple case reports describe dramatic relief of hiccups lasting several days in advanced cancer patients after gabapentin was started.17PubMed Central. Successful Treatment of Persistent Hiccups in an Advanced Palliative Cancer Patient With Gabapentin: A Case Report18PubMed Central. Gabapentin in the treatment of persistent hiccups in advanced malignancy It works on nerve signaling in ways that may dampen the overactive reflex arc. Baclofen, a muscle relaxant that affects GABA receptors, has a longer track record but can cause drowsiness. Metoclopramide works on dopamine receptors and also helps with the nausea that often accompanies chemo, which makes it a practical two-for-one choice in some situations. Haloperidol has been used for decades as a hiccup treatment but carries more significant side effects, so it tends to be reserved for cases that don’t respond to gentler options.
The choice of medication usually depends on what other symptoms you’re dealing with, what drugs you’re already taking, and your doctor’s clinical experience. There’s no strong head-to-head data ranking these drugs against each other for chemo-induced hiccups specifically.
Non-Drug Approaches and Home Remedies
Before reaching for a prescription, many patients and clinicians try physical maneuvers. The classic remedies you’ve heard of, like holding your breath, drinking cold water, biting a lemon, or swallowing granulated sugar, all work on the same general principle: they stimulate the vagus nerve or disrupt the hiccup reflex arc through sensory input. These are harmless to try, though they tend to work better for brief hiccup bouts than for the persistent kind that chemo can produce.
A more structured approach has emerged with a device called FISST (Forced Inspiratory Suction and Swallow Tool), essentially a rigid straw with a valve that requires you to suck hard to draw water through it, then swallow. The forceful inhalation engages the diaphragm and phrenic nerve while swallowing stimulates the vagus nerve, hitting two parts of the hiccup reflex at once. In a general-population survey study, FISST stopped hiccups in about 92 percent of cases and was rated more effective and more practical than traditional home remedies by around 90 percent of users.19JAMA Network Open. Evaluation of the Forced Inspiratory Suction and Swallow Tool to Stop Hiccups
More recently, FISST was tested specifically in chemotherapy patients. Among 19 patients who developed hiccups after chemo, use of the device reduced the median number of hiccup episodes per minute from 6 down to 0.3, and discomfort scores dropped substantially. One patient experienced brief aspiration during use, and three others were excluded from the trial because of aspiration during the practice session, which is a reminder that any device involving swallowing needs to be used with some care in debilitated patients.20PubMed. Evaluation of the Forced Inspiratory Suction and Swallow Tool for Chemotherapy-Induced Hiccups Still, for most patients it represents a simple, drug-free option that can be tried alongside other treatments.
A large randomized trial also tested a set of behavioral and physical interventions taught to patients before chemotherapy, including deep-breathing exercises, acupressure, and relaxation techniques. The trial enrolled 654 patients and found that those trained in these techniques had a slightly higher reported rate of acute hiccups than the control group, which was unexpected and suggests that awareness of the symptom may have increased reporting rather than that the techniques caused hiccups. The data are still being interpreted, but the study represents one of the first serious randomized efforts to address chemo hiccups with non-drug tools.4PubMed Central. Patient-directed behavioral-physical interventions to alleviate acute hiccups associated with chemotherapy: a prospective randomized controlled trial
Talking to Your Oncology Team
One of the biggest barriers to getting relief is that patients don’t always bring hiccups up. Compared to nausea, neuropathy, or hair loss, hiccups can feel trivial, something to endure rather than report. But given that effective fixes exist, particularly steroid rotation, there is real value in mentioning it. Your oncologist needs to know whether your hiccups are tied to the timing of dexamethasone, how long they last, and whether they are affecting your eating, sleeping, or overall energy. That information shapes the decision about whether a simple steroid swap could solve the problem or whether additional medications should be tried.
It is also worth keeping a brief log of when hiccups start relative to your infusion, how long they last, and how severe they are. This kind of detail helps distinguish dexamethasone-related hiccups from hiccups caused by the tumor itself, electrolyte changes, or other medications. The pattern matters: if hiccups reliably start the day after chemo and fade within two days, the steroid is the prime suspect. If they appear at random times unrelated to treatment, other causes need to be investigated.
Hiccups and Specific Chemotherapy Regimens
Platinum-based chemotherapy, particularly cisplatin and oxaliplatin, appears in the literature most often in connection with hiccups. But this is at least partly because these drugs require aggressive anti-nausea regimens that include high-dose dexamethasone and NK1 receptor antagonists, both of which are independently associated with hiccups. Separating the effect of the platinum drug from the effect of its supportive medications is genuinely difficult, and some researchers have argued that we may be overattributing hiccups to the chemotherapy agents when the support drugs deserve more of the blame.5PubMed. Severe hiccups during chemotherapy: corticosteroids the likely culprit
Other chemotherapy drugs have been reported to cause hiccups as well, though less consistently. Carboplatin, etoposide, and some targeted therapies have appeared in isolated case reports. In most of those situations, though, the patient was also receiving dexamethasone, which makes it hard to pin down whether the chemotherapy drug was the trigger. When evaluating your own situation, the key question to work through with your team is not just “which chemo drug am I on” but “what is the full medication cocktail, and which component is most likely causing this?”
When Hiccups Become Intractable
Medical literature distinguishes between hiccup bouts (lasting under 48 hours), persistent hiccups (lasting more than 48 hours), and intractable hiccups (lasting more than a month). Most chemo-related hiccups fall in the first two categories. Truly intractable hiccups are rare but can be debilitating, causing weight loss, insomnia, depression, and sometimes aspiration of food or liquid. In these cases, treatment escalates beyond the standard drugs mentioned earlier. Options include nerve blocks targeting the phrenic nerve, and in one case report, pulsed radiofrequency applied to the phrenic nerve provided relief for a lung cancer patient whose tumor was invading the diaphragm.12Journal of Hospice and Palliative Care. Treatment of Lung Cancer-Related Intractable Hiccups Using Pulsed Radiofrequency: Clinical Experience These are last-resort interventions, but they exist, and palliative care teams are generally aware of them. If you or someone you know is dealing with hiccups that have resisted everything else, a referral to palliative care or a pain specialist is worth requesting.